@misc{10481/68146,
year = {2021},
month = {3},
url = {http://hdl.handle.net/10481/68146},
abstract = {Simple Summary

Acute myeloid leukemia (AML) is a hematological neoplasm with a very poor survival rate. To date, diagnostic tools to monitor individuals at higher risk of developing AML are scarce. Single nucleotide polymorphisms (SNPs) have emerged as good candidates for disease prevention. AML is characterized by altered autophagy, a vital mechanism to remove and recycle unnecessary or dysfunctional cellular components. ATG10 is one of the autophagy core genes involved in the autophagosome formation. We hypothesize that SNPs located in regulatory regions of the ATG10 gene could predispose individuals to AML development. We therefore genotyped three SNPs within the ATG10 locus. We identified the ATG10(rs3734114) as a potential risk factor for developing AML, whereas the ATG10(rs1864182) was associated with decreased risk. These findings highlight ATG10 as a key regulator of susceptibility to AML. Furthermore, we believe that ATG10 SNPs could be exploited in the clinical setting as an AML prevention strategy.

Acute myeloid leukemia (AML) is the most common acute leukemia, characterized by a heterogeneous genetic landscape contributing, among others, to the occurrence of metabolic reprogramming. Autophagy, a key player on metabolism, plays an essential role in AML. Here, we examined the association of three potentially functional genetic polymorphisms in the ATG10 gene, central for the autophagosome formation. We screened a multicenter cohort involving 309 AML patients and 356 healthy subjects for three ATG10 SNPs: rs1864182T>G, rs1864183C>T and rs3734114T>C. The functional consequences of the ATG10 SNPs in its canonical function were investigated in vitro using peripheral blood mononuclear cells from a cohort of 46 healthy individuals. Logistic regression analysis adjusted for age and gender revealed that patients carrying the ATG10(rs1864182G) allele showed a significantly decreased risk of developing AML (OR [odds ratio] = 0.58, p = 0.001), whereas patients carrying the homozygous ATG10(rs3734114C) allele had a significantly increased risk of developing AML (OR = 2.70, p = 0.004). Functional analysis showed that individuals carrying the ATG10(rs1864182G) allele had decreased autophagy when compared to homozygous major allele carriers. Our results uncover the potential of screening for ATG10 genetic variants in AML prevention strategies, in particular for subjects carrying other AML risk factors such as elderly individuals with clonal hematopoiesis of indeterminate potential.},
organization = {European Commission},
organization = {Portuguese Foundation for Science and Technology

European Commission

POCI-01-0145-FEDER-028159
POCI-01-0145-FEDER-030782},
organization = {Instituto de Salud Carlos III

ISCIII-FEDER PI20/01845
ISCIII-FEDER PI12/02688
ISCIII-FEDER PI17/02276},
organization = {Portuguese Foundation for Science and Technology

European Commission

POCI-01-0145-FEDER-028159
DL 57/2016
CEECIND/04058/2018
CEECIND/03628/2017},
publisher = {MDPI},
keywords = {Acute myeloid leukemia},
keywords = {ATG10},
keywords = {Autophagy},
keywords = {Single nucleotide polymorphism},
title = {Functional Genetic Variants in ATG10 Are Associated with Acute Myeloid Leukemia},
doi = {10.3390/cancers13061344},
author = {Castro, Isabel and Sánchez Maldonado, José Manuel and Sáinz Pérez, Juan},
}